Our data as revealed by western blot analysis, showed statistically significant increased p53 protein levels in COPD patients compared to non-COPD smokers (Figure 2), while the immunohistochemistry revealed increased p53 ratio in PN II in COPD patients (Figure 3) compared to non-COPD smokers. Here, TP53 is linked to chronic obstructive pulmonary disease.